Skip to main content
Premium Trial:

Request an Annual Quote

NimbleGen Taps Global Business VP; Poste Joins Caris' Board; NextGen Hires Third Wave Alumnus to Run Global Sales; and Others

NEW YORK (GenomeWeb News) — NimbleGen Systems has named Gregory McGuinness to be its vice president of international business, the company said.
 
McGuinness is former director of European business development for Gene Logic, and was director of channel management for Affymetrix and director of sales and distributor relations for Genetic Microsystems. He also worked with Stratagene, PerkinElmer, and Applied Biosystems.


Caris Diagnostics has named George Poste as an outside director to its board of directors, the company said this week.
 
Poste is a senior technical advisor at Caris, which has a controlling stake in Caris Diagnostics.
 
Poste also is director of the Biodesign Institute at Arizona State University, a biotech/nanotech program, and he is chief executive at Health Technology Networks a genomics consulting company.
 
Poste is a fellow of the Royal Society and the UK Academy of Medicine, a distinguished fellow at the Hoover Institution of Stanford University and a member of the Council for Foreign Relations.

 
NextGen has appointed Jake Orville as vice president of global sales, the company said.
 
Orville comes to NextGen from Third Wave Technologies, where as vice president of sales and business development.
 
Orville takes over for Geoff Alms, who moves to a lead role in North American Development.


Gene Express has appointed Colette Saccomanno to be the company's director of business development, the company said today.
 
Saccomanno, who has a sales and marketing background, most recently was program manager at ArisGlobal and was a senior account executive at Galt Associates. She also served as account executive at Covance Laboratories'
Early Development segment, which is now Abbot Molecular, and at Bio-Rad Laboratories.

 
GeneNews has named Roman Zastawny vice president of biomarker development, the company said this week. Zastawny will run product development but will focus on getting the company's ColonSentry ready to take to market.
 
The company said Zastawny has been vice president of R&D at Tm Bioscience, where he led a team to gain FDA clearance for a cystic fibrosis diagnostic, and as vice president of development at Novx Systems, where he worked to get a product cleared by Canadian health officials.

 
Transgenomic has hired Debra Schneider to be the company's vice president and chief financial officer as of Dec. 4, the company said.
 
Schneider comes to Transgenomic from First Data Corporation, where for 17 years she worked in various capacities, including serving as CFO for business interests and as vice president of finance.

 
Sigma-Aldrich's board of directors elected Steven Paul to be a company director, Sigma said this week.
 
Paul currently is executive vice president for science and technology and president of the Lily Research Laboratories of Eli Lilly.
 
Before working at Eli Lilly Paul served as scientific director of the National Institutes of Health.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.